Emphysematous Pyelonephritis Complicated With Hyperglycemic Hyperosmolar State and Sepsis: A Case Report and Literature Review.

Autor: Fernandez Felix DA; Medicine, SBH (St. Barnabas Hospital) Health System, New York City, USA.; Clinical Medicine, City University of New York School of Medicine, New York City, USA., Madrigal Loria G; Medicine, SBH (St. Barnabas Hospital) Health System, New York City, USA.; Clinical Medicine, City University of New York School of Medicine, New York City, USA., Sharma S; Medicine, SBH (St. Barnabas Hospital) Health System, New York City, USA.; Clinical Medicine, City University of New York School of Medicine, New York City, USA., Ali M; Medicine, SBH (St. Barnabas Hospital) Health System, New York City, USA.; Clinical Medicine, City University of New York School of Medicine, New York City, USA., Arias Morales CE; Medicine, SBH (St. Barnabas Hospital) Health System, New York City, USA.; Clinical Medicine, City University of New York School of Medicine, New York City, USA.
Jazyk: angličtina
Zdroj: Cureus [Cureus] 2022 May 30; Vol. 14 (5), pp. e25498. Date of Electronic Publication: 2022 May 30 (Print Publication: 2022).
DOI: 10.7759/cureus.25498
Abstrakt: Emphysematous pyelonephritis (EPN) is an acute life-threatening necrotizing infection of the renal parenchyma and perirenal tissues. There are multiple treatment strategies for EPN depending on the initial classification; over the last three decades, the treatment approach has favored kidney sparing strategies and the use of nephrectomy only as salvage therapy. We report a case involving a patient with unilateral emphysematous pyelonephritis complicated with hyperglycemic hyperosmolar state (HHS), sepsis, and multiple risk factors associated with poor prognosis who was successfully treated with conservative management sparing nephrectomy. This case report aims to create awareness among clinicians that even in the presence of multiple risk factors for poor prognosis, conservative management should be considered before nephrectomy.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2022, Fernandez Felix et al.)
Databáze: MEDLINE